Benjamin Edwards Inc’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$795K Sell
13,535
-4,230
-24% -$177K 0.01% 888
2026
Q1
$572K Sell
17,765
-950
-5% -$35.2K 0.01% 952
2025
Q4
$788K Sell
18,715
-3,766
-17% -$152K 0.01% 797
2025
Q3
$772K Sell
22,481
-1,121
-5% -$32.2K 0.01% 783
2025
Q2
$638K Sell
23,602
-2,222
-9% -$64.4K 0.01% 770
2025
Q1
$766K Sell
25,824
-1,086
-4% -$41.4K 0.01% 667
2024
Q4
$1.07M Sell
26,910
-1,607
-6% -$60.8K 0.02% 591
2024
Q3
$971K Buy
28,517
+28,305
+13,351% +$796K 0.01% 610
2024
Q2
$5K Sell
212
-114
-35% -$2.4K ﹤0.01% 647
2024
Q1
$7K Buy
326
+14
+4% +$342 ﹤0.01% 662
2023
Q4
$9K Sell
312
-254
-45% -$6.13K ﹤0.01% 590
2023
Q3
$13K Sell
566
-1
-0.2% -$26 ﹤0.01% 561
2023
Q2
$14K Buy
567
+1
+0.2% +$24 ﹤0.01% 553
2023
Q1
$13K Buy
566
+31
+6% +$749 ﹤0.01% 559
2022
Q4
$13K Buy
535
+123
+30% +$2.86K ﹤0.01% 558
2022
Q3
$7K Sell
412
-9
-2% -$203 ﹤0.01% 599
2022
Q2
$8K Buy
421
+35
+9% +$707 ﹤0.01% 606
2022
Q1
$11K Buy
386
+44
+13% +$1.26K ﹤0.01% 603
2021
Q4
$14K Buy
+342
New +$15.1K ﹤0.01% 557

Other funds holding VCYT

Benjamin Edwards Inc's VCYT Position: Q2 2026 in Review

Benjamin Edwards Inc reduced its Veracyte (VCYT) stake by 24% in Q2 2026, selling an estimated $177K and leaving 13,535 shares worth $795K. The position accounts for 0.01% of the portfolio, ranked #888.

Benjamin Edwards Inc first reported a position in VCYT in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.07M in Q4 2024. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Benjamin Edwards Inc held 13,535 shares of Veracyte worth $795K as of Q2 2026.
  • Benjamin Edwards Inc sold 4,230 Veracyte shares in Q2 2026, an estimated $177K.
  • Veracyte made up 0.01% of Benjamin Edwards Inc's portfolio in Q2 2026, its #888 holding.
  • Benjamin Edwards Inc first reported a position in Veracyte in Q4 2021 and has held it in 19 quarters since.
  • Benjamin Edwards Inc's Veracyte position peaked at $1.07M in Q4 2024.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Benjamin Edwards Inc's 13F filing for Q2 2026, filed 24 Jul 2026.